The global monoclonal antibody therapy market is poised for a remarkable surge in the coming years, fueled by advancements in biotechnology and the increasing demand for targeted therapies for various diseases. According to a recent industry report, the market, valued at USD 87.8 billion in 2023, is expected to reach a staggering USD 230.38 billion by 2031, reflecting a robust...